The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 strategy notes that exacerbation history is the best predictor of future exacerbations in patients with chronic obstructive pulmonary disease (COPD) (1); in addition, blood eosinophil level has been suggested as a potential biomarker for exacerbation risk and a predictor of efficacy of inhaled corticosteroids (ICS) in preventing exacerbations in COPD patients at a risk of exacerbations.
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study
Papi, Alberto
Primo
;
2018
Abstract
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 strategy notes that exacerbation history is the best predictor of future exacerbations in patients with chronic obstructive pulmonary disease (COPD) (1); in addition, blood eosinophil level has been suggested as a potential biomarker for exacerbation risk and a predictor of efficacy of inhaled corticosteroids (ICS) in preventing exacerbations in COPD patients at a risk of exacerbations.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
rccm.201709-1822le.pdf
solo gestori archivio
Tipologia:
Full text (versione editoriale)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
575.44 kB
Formato
Adobe PDF
|
575.44 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
papi2017.pdf
accesso aperto
Descrizione: Post print
Tipologia:
Post-print
Licenza:
PUBBLICO - Pubblico con Copyright
Dimensione
427.7 kB
Formato
Adobe PDF
|
427.7 kB | Adobe PDF | Visualizza/Apri |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
